Condition : Juvenile Idiopathic Arthritis Interventions : Drug: CNTO 148 (Golimumab); Drug: Placebo; Drug: Methotrexate Sponsors : Janssen Research & Development, LLC; Janssen Research & Development,...

Condition : Juvenile Idiopathic Arthritis Interventions : Biological: CNTO 148 (Golimumab); Biological: CNTO 148 (golimumab) or placebo Sponsors : Centocor, Inc.; Schering-Plough (Ireland) Company Rec...

Condition : Juvenile Idiopathic Arthritis Interventions : Biological: CNTO 148 (Golimumab); Biological: CNTO 148 (golimumab) or placebo Sponsors : Centocor, Inc.; Schering-Plough (Ireland) Company Rec...

Conditions : Arthritis; Rheumatoid Intervention : Drug: etanercept (genetical recombination) Sponsors : Pfizer; Pfizer Completed - verified September 2013

Conditions : Arthritis; Rheumatoid Intervention : Drug: etanercept (genetical recombination) Sponsor : Pfizer Completed - verified November 2013

Conditions : Arthritis; Rheumatoid Intervention : Drug: etanercept (genetical recombination) Sponsor : Pfizer Recruiting - verified August 2011

Condition : Osteoarthritis Intervention : Sponsor : Heinrich-Heine University, Duesseldorf Recruiting - verified July 2011

Conditions : Osteoarthritis, Knee; Knee Injuries; Joint Diseases; Rheumatic Diseases; Cartilage Diseases Intervention : Other: Autologous MSC knee implantation Sponsors : Banc de Sang i Teixits; Banc...

Conditions : Osteoarthritis, Knee; Knee Injuries; Joint Diseases; Rheumatic Diseases; Cartilage Diseases Intervention : Other: Autologous MSC knee implantation Sponsors : Banc de Sang i Teixits; Centr...

Condition : Rheumatoid Arthritis Interventions : Drug: adalimumab; Drug: leflunomide; Drug: methotrexate; Drug: MLTA3698A; Drug: placebo Sponsors : Genentech; Genentech Completed - verified September...